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Abstract The HvCNG channel from the moth Heliothis
virescens is highly sensitive to cAMP concentrations
ranging between 0.1 µM and 5 µM. This HvCNG chan-
nel was over-expressed in Spodoptera frugiperda (Sf.9)
cells to measure endogenous cAMP levels. Hyperpolar-
ization-activated inward currents were measured in the
whole-cell patch-clamp configuration with pipettes filled
with different cAMP concentrations to calibrate the
system. Varying the cAMP concentration between 0 µM
and 100 µM in the pipette, the half-maximal activation
voltage (V1/2) was shifted by +28.5±1.7 mV. The activa-
tion time constant (τa) was used as a parameter for
cAMP quantification because it was independent of the
expression level of HvCNG channels. τa changed from
1106±60 ms at 0 µM cAMP to 265±7 ms at a saturating
concentration of 1 mM cAMP. A dose–response relation-
ship yielded values of 0.6 µM for the half-maximal
cAMP concentration and 1.5 for the Hill coefficient. Ac-
tivation of endogenous adenylyl cyclases by 50 µM for-
skolin induced an elevation of the cAMP level by about
1.6±0.2 µM. Co-expressions of HvCNG channels in
combination with the mouse 5-HT4(a)- or 5-HT1A- recep-
tors and the corresponding Gs- or Gi-proteins were suc-
cessful and allowed us to also verify receptor-induced
changes of the cAMP level. Stimulation of m5-HT4(a)-re-
ceptors by 0.1 µM 5-HT induced an increase of cAMP of
about 4.6±1.5 µM, whereas cAMP levels decreased from
a control value of 1±0.2 µM to 0.41±0.1 µM after stimu-
lation of the m5-HT1A-receptors.
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Introduction
The second messenger cAMP has indirect effects on
many processes, but one of its direct functions is to mod-
ulate the opening kinetics of certain ion channels. Two
closely related families of such ion channels are the cy-
clic-nucleotide-gated cation channels (CNG) (for review
[10, 33]) and the hyperpolarization-activated cation
channels (HCN) that generate the hyperpolarization-acti-
vated cation currents Ih, If or IQ (for review [21, 27]).
The open probability of both types of ion channels and
their opening kinetics change in relation to the cGMP
and cAMP concentrations [8, 10, 24]. The molecular
structure that is responsible for such behaviour is the cy-
clic-nucleotide-binding domain (CNBD) on the C-termi-
nal of each of the four channel subunits. In both channel
types the CNBDs are similar in their amino acid se-
quence, but HCN channels are about 10- to 1000-fold
more sensitive to cAMP than CNG channels [10, 27, 35].
The intracellular cAMP level depends mainly on the
activity of two enzymes, the adenylyl cyclases (AC) ca-
talysing cAMP production and the phosphodiesterases
(PDE) degrading the cAMP. Guanine-nucleotide-binding
proteins (G-proteins) activated by certain metabotropic
receptors are physiological regulators of the AC's [12,
19] and are known to modulate HCN channels (Ih)
through intracellular cAMP [5, 11, 22]. These estab-
lished functions encouraged us to use a HCN channel as
a cellular biosensor for monitoring regulatory changes in
cAMP concentrations.
We used the baculovirus expression system in Sf.9
cells, in which HCN channels were co-expressed with a
serotonin (5-HT) receptor and G-proteins from mouse.
The specific HCN channel type used in the present study
was cloned from an antennal cDNA library of the moth
Heliothis virescens, which represents a cyclic-nucleo-
tide- and voltage-activated cation channel (HvCNG) be-
longing to the HCN gene family [14]. The m5-HT4(a)-re-
ceptor isoform is described to activate ACs via a Gs-pro-
tein [3, 9], while the m5-HT1A-receptor is known to re-
duce the intracellular cAMP level via a Gi-protein, espe-
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cially due to its coupling to the αi-subunit [3]. However,
the m5-HT1A-receptor can also elevate the cAMP level
through the β/γ-subunits [2, 16] that activate ACs.
In order to calibrate the endogenous sensitivity of
HvCNG channels, we analysed the activation kinetics of
the HvCNG current to gain a quantitative parameter for
determining intrinsic cAMP levels. The experiments
proved that the system is valid for obtaining information
about the coupling efficacy between receptor and G-pro-
tein subunits.
Materials and methods
Construction of recombinant baculovirus
All basic DNA procedures were performed as described elsewhere
[26]. Dr. Aline Dumuis (Montpellier; France) kindly provided us
with the m5-HT4(a) gene. The m5-HT4(a) cDNA was cleaved with
XbaI and HindIII endonucleases to yield the 1.1-kb fragment con-
taining the entire coding sequence. The fragment was ligated to
the XbaI and HindIII sites in the multiple cloning site of the
pFastBac donor plasmid (Life Technologies; Eggenstein-Leopold-
shaven, Germany). The cDNA encoding for the m5-HT1A-receptor
was kindly provided by Dr. Paul Albert (Montreal, Canada). The
m5-HT1A gene was cut out from pBlueScript plasmid with EcoRI
and then ligated into EcoRI site in MCS of pFastBac vector. The
final plasmids were transfected into the DH10Bac E. coli cells
containing bacmid and helper DNA. Recombinant bacmid DNA
was purified, checked for the existence of m5-HT1A or m5-HT4(a)
genes by PCR with receptor-specific primers and then transfected
into Spodoptera frugiperda (Sf.9) cells by the Cellfectin reagent
(Life Technologies; Eggenstein-Leopoldshaven, Germany). Final-
ly, the recombinant viruses were purified and amplified as de-
scribed previously [32].
Expression of recombinant proteins in Sf.9 cells
The recombinant HvCNG/AcNMPV baculovirus was a gift from
Professor H. Breer (Stuttgart) [14]. For expression of HvCNG
channels, Sf.9 cells (1.5×106) grown in TC 100 medium (Life
Technologies; Eggenstein-Leopoldshaven, Germany) supplement-
ed with 10% fetal calf serum (FCS) and 1% penicillin/streptomy-
cin in 35-mm dishes were infected with recombinant baculovirus
at multiplicity of infections (m.o.i.) of 10. For the co-expression
experiments, Sf.9 cells were infected with HvCNG channels and
also with recombinant baculoviruses encoding for the m5-HT4(a)-
receptor or the m5-HT1A-receptor, the αs- or the αi-subunit as well
as β1/γ2-subunits of trimeric G-proteins beside the HvCNG chan-
nel at a m.o.i. of at least 1 for each type of virus. After 48 h post-
infection Sf.9 cells were used for electrophysiological or Western
blot analysis.
SDS-PAGE and Western blotting
Sf.9 cells expressing m5-HT4(a)-receptors, HvCNG channels, Gαs-,
Gβ1- and Gγ2-subunits were scraped into medium 48 h post-infec-
tion and washed in ice-cold PBS (140 mM NaCl, 3 mM KCl,
2 mM KH2PO4, 6 mM Na2HPO4, pH 7.4). Cells were than resus-
pended in Tris/EDTA buffer (10 mM Tris/HCl, pH 8.0, 1 mM ED-
TA) and boiled for 3 min in non-reducing electrophoresis sample
buffer (62.5 mM Tris-HCl, pH 6.8, containing 20% glycerol, 6%
SDS, 0.002% bromphenol blue). Proteins were separated by SDS-
PAGE on 10% acrylamide gels using standard procedures. After
the SDS-PAGE was completed, the proteins were blotted to a
PVDF transfer membrane (Hybond-P; Amersham, Germany) us-
ing a semi-dry blotter at 5 mA per cm2. Membranes were probed
for m5-HT4(a)-receptors with antibodies AS9459 raised against the
C-terminal peptide of m5-HT4(a) [23] at a 1:1000 dilution. For Gβ1
and Gγ2 we used antibodies AS398 against β-subunits (β1+β4) and
AS292 against the γ-subunits (γ2+γ3) at a dilution of 1:500 [15].
m5-HT1A-receptors and Gαs-subunits were detected by using anti-
m5-HT1A-receptor and anti-Gαs rabbit polyclonal antibodies at a
dilution of 1:500 (Santa Cruz; Heidelberg, Germany). Detection
was achieved with the enhanced chemiluminescence kit (ECL
Plus; Amersham, UK). Protein bands were visualized by fluorog-
raphy using Kodak X-Omat AR films and film exposure times
ranging between 10 s and 60 min.
Electrophysiology
HvCNG currents were recorded in the whole-cell patch-clamp
mode. Borosilicate glass pipettes were fire polished and had a re-
sistance of 4–8 MΩ. We used the discontinuous single-electrode
voltage-clamp amplifier SEC-05L from npi-electronic (Tamm,
Germany), which was connected with an ITC-16 interface from
Instrutech (Greatneck, N.Y., USA). Data were acquired with a
computer, stored by Pulse-PulseFit 8.31 software from HEKA
(Lambrecht, Germany) and analysed with Igor-WaveMetrics soft-
ware (Oregon, USA).
The measurements were performed using TC 100 medium
(Life Technologies; Eggenstein-Leopoldshaven, Germany) with-
out FCS. In this medium it was possible to keep cells intact for
4–7 h. The temperature of the bath solution was held at 25±0.2°C
with a Peltier-element-gated control unit from ESF-electronic
(Goettingen, Germany).
The standard pipette solution contained (in millimolar concen-
trations): 110 K-gluconate, 1 CaCl2, 2 MgCl2, 2 Na2ATP, 0.4 GTP,
10 HEPES, 10 EGTA and was adjusted to pH 7.25 with KOH
shortly before use. The high gluconate concentration of the intra-
cellular solution resulted in a liquid junction potential (measured
according to [20]) of –4 mV, which was subtracted from potentials
in Fig. 1, 2 and 4. The highly Ca2+-buffered (10 mM EGTA) pi-
pette solution containing 15.3 nM free Ca2+ concentration (“patch-
er power tools” software written by Francisco Mendez, Göttingen)
was used, because the possible role of Ca2+ ions in the modulation
of channel activation kinetics remains controversial [4, 18]. In
some experiments, Na-cAMP was added in varying concentrations
to the pipette solution to calibrate the changes of current kinetics
in response to different cAMP concentrations. The osmolarity of
the pipette solution was adjusted to 20 mosmol below the osmo-
larity of TC 100 medium. Endogenous AC were activated by
50–100 µM forskolin and blocked by 30 µM MDL 12–330A,
while the m5-HT4a-receptor and m5-HT1A-receptor were stimulat-
ed with 0.1–50 µM serotonin (5-HT).
Drugs were applied to individual cells by pressure application
(PDES 2L-unit from npi-electronic, Tamm, Germany) through pi-
pettes (diameter of 3–5 µm) or applied to the bath solution. All
chemicals were purchased from Sigma Aldrich (Germany), Merck
(Darmstadt, Germany), Tocris (Bristol, UK) and Calbiochem (Bad
Soden, Germany).
Data fitting
Leakage currents were automatically subtracted from the original
recordings before analysis by a P/4 protocol. Two types of fittings
were performed: an exponential fit of the time course of channel
activation and a Boltzmann fit of the steady-state activation of tail
currents. The activation time constants were fitted by the equation
I(t)=I0+I1·[1–exp(–t/τ)], where I0 is the current at the beginning of
activation and I1 is the maximal current at the end of the applied
voltage pulses. The exponent –t/τ represents the ratio between the
time t and the activation time constant τ. The fits were performed
for all data points collected between the minima of the first time
derivative of the current and the maximal current amplitude at the
end of the voltage pulse (Fig. 1B). For the Boltzmann fit of the
steady-state activation curve of HvCNG current we used equation
P
∞
(Vm)=1/{1+exp [(Vm−Vh)/k]}, where P∞(Vm) denotes the steady-
state open probability P
∞
of HvCNG channels at a membrane po-
tential Vm, Vh is the half-activation voltage of the HvCNG current,
and k is the slope factor. cAMP levels were calculated from the
dose–response relationship shown in Fig. 1C. Data for the
dose–response curve were fitted by a Hill equation with variable
slope τmin+(τmax–τmin)/1+(c1/2/c)n, where τmin is the time constant
at 0 cAMP, τmax is the time constant at 1 mM cAMP, c1/2 is the
half-maximal cAMP concentration and n is the Hill factor. To cal-
culate the cAMP concentration for each time constant between
τmin and τmax we converted the Hill equation to:
Statistical values are given as means ±SEM.
Results
Sf.9 cells are spherical cells with a diameter ranging be-
tween 10 µm and 15 µm. Activation of the recombinant
m5-HT4(a)-/m5-HT1A-receptor-controlled second mes-
senger cascade was functional in these cells and the
stimulation of intracellular ACs by forskolin was partial-
ly reversible. This suggests that wash-out effects did not
affect the cAMP-induced changes in channel kinetics.
This enabled us to measure intracellular concentrations
of cAMP with a technique relying on patch-clamp re-
cordings.
Estimation of cAMP levels
The absolute current amplitudes varied largely between
individual cells depending on the expression level of
HvCNG channels in Sf.9 cells. The maximal currents
varied between 0.1 nA and 2.5 nA when –100-mV puls-
es lasting for 1 s were applied.
In order to be independent of the expression levels of
HvCNG channels, we measured two kinetic parameters:
the half-maximal activation voltage (V1/2) and the volt-
age-dependent activation time constant (τa) near V1/2(–100 mV; Figs. 1A, C, 2). A dose–response curve of
cAMP concentrations was determined by loading cells
with various concentrations of Na-cAMP added to the
pipette solution. The current activation by hyperpolariz-
ing pulses stepping from –10 mV to –100 mV was well
fitted by a single exponential curve. The τa value was
cAMP dependent and changed from 1106±60 ms at
0 µM cAMP (n=9) to 265±7 ms at 1 mM cAMP (n=3)
(Fig. 1C). In the presence of 30 µM MDL 12330A, a
blocker of ACs [13], the τa value for 0 cAMP was not
significantly different, namely 1115±86 ms (n=8).
Measurements were not started for at least 5 min after
establishing the whole-cell configuration, so as to allow
equilibration of the cAMP concentrations between the
pipette solution and the cytosol (Fig. 1B). The activation
curve as determined by tail currents was fitted by the
Boltzmann equation and showed a pronounced voltage
420
Fig. 1A–C Activation kinetic of the HvCNG channel with differ-
ent free cAMP concentrations in the pipette solution (whole cell).
A Activation constants were yielded from exponential fits of cur-
rents at voltage pulses between –150 and –90 mV (left). Voltage
protocol and elicited currents (right) are shown. B The determina-
tion of time constants induced by 0.5 µM cAMP in the pipette so-
lution indicates the time course of the equilibration of the intracel-
lular milieu with the pipette solution after establishing the whole-
cell configuration. Each point represents the activation time con-
stant (τa) of a 1-s-long pulse to –100 mV (left). Values were re-
vealed from single exponential fits at different times as shown for
four current traces. To have a defined start and end point, currents
were fitted from the minimum of the first time derivative to the
end of the pulse as seen in the example (right). C τa shown for dif-
ferent cAMP concentrations (mean ±SEM). τa was determined for
hyperpolarizing steps from the holding potential to –100 mV. The
data indicate a half-maximal activation at 0.62 µM cAMP and a
Hill coefficient of 1.51
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shift by maximally +28.5±1.7 mV (n=3), when cAMP
varied between 0 µM and 100 µM (Fig. 2).
The activation time constants as measured at different
cAMP concentrations were fitted by a Hill equation
(Fig. 1C). We determined values of 0.62 µM for the half-
maximal cAMP concentration (Ka) and 1.51 for the Hill
coefficient (n). The Ka value was slightly lower than the Ka
of 0.76 µM as reported elsewhere [14] using inside-out
patches. However, the Ka determined in the present experi-
ments is in good agreement with measurements made from
other heterologously expressed HCN channels [8, 17, 28].
Changes of current kinetics through activation 
of endogenous adenylyl cyclases
Sf.9 cells have an endogenous steady-state level of intra-
cellular cAMP. Experiments to measure this endogenous
level of cAMP were performed on Sf.9 cells that were
infected only by the HvCNG channel. The first –100 mV
pulse immediately after establishing the whole-cell con-
figuration was used to determine the basal cAMP level
of the cells. We assumed a negligible degree of diffusion
from the pipette into the cytosol after such a short time
of about 10–20 s. The averaged mean τa value was
517±33 ms (n=49) and indicated a basal cAMP concen-
tration of 1.5±0.3 µM. Incubation of cells in 30 µM
MDL 12330A for at least 30 min shifted the τa value to
688±62 ms (n=15), which indicates a basal cAMP con-
centration of 0.9±0.1 µM. However, the τa values were
not significantly different (unpaired t-test, P=0.097).
Application of 50 µM forskolin shifted the value for
V1/2 in the positive direction by +12.9±2.8 mV (n=3),
while the τa value was reduced from 730±79 ms to
353±45 ms (n=6). The calculated τa corresponded with
an increase of intracellular cAMP levels by 1.6±0.2 µM.
The delay between drug application and maximal activa-
tion was found to be 87±5 s. Such activation of endoge-
nous ACs was only partially reversible (Fig. 3A).
Fig. 2 Tail current analysis for three different cAMP concentra-
tions. Tail currents were measured at the time indicated by the ar-
row. Normalized tail current amplitudes were fitted by a Boltz-
mann equation. The fitting values are V1/2=–102.9±2.03 mV, slope
= 11.3±0.82 for 0 cAMP (n=8), V1/2=–90.6±2.82 mV, slope =
12.2±1.6 for 1 µM cAMP (n=4), V1/2=–74.5±1.71 mV, slope =
8.85±1.9 for 100 µM cAMP (n=3) Fig. 3A–C Stimulation of Sf.9 cells expressing the recombinant
HvCNG channel by 50 µM forskolin. A Time course of forskolin-
induced decrease of τa fitted by single exponential functions and
the calculated cAMP concentration are shown. The time to reach
maximal activation was 87±5 s. τa was decreased from 730±79 ms
to 353±45 ms (n=6). B Time course of forskolin-induced decrease
of τa fitted by single exponentials in the presence of 10 µM stauro-
sporine. The time to reach maximal activation was 157±23 s. τa
was decreased from 749±117 ms to 465±76 ms (n=3). C Time
course of forskolin-induced decrease of τa fitted by single expo-
nentials in the presence of 1 µM PKI 6–22 amide. The time to
reach maximal activation was 176±25 s. τa was decreased from
656±55 ms to 423±18 ms (n=5)
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Involvement of protein kinases in channel activation
In order to verify that protein kinases do not modify the
opening kinetics of HvCNG channels in addition to free
cAMP, we applied two kinase antagonists. Staurosporine
(10 µM) was used to block protein kinase C (PKC) as
well as cAMP-dependent protein kinase (PKA). PKI
6–22 amide (1 µM) was applied to specifically block
PKA. Neither antagonist had any influence on current ki-
netics when applied through the patch pipette or when ap-
plied extracellularly by local pressure ejection. The V1/2
values did not change significantly and additional appli-
cation of 50 µM forskolin affected the kinetics of the cur-
rent in the same way as did forskolin application alone.
The V1/2 values induced by forskolin changed by about
+10.6±1.3 mV (n=3) after staurosporine application and
by about +11.5±1.3 mV (n=5) after the application of
PKI 6–22 amide. Forskolin-induced (50 µM) modulation
of τa changed from 749±117 ms to 465±76 ms (n=3) in
the presence of 10 µM staurosporine, and from 656±55 to
423±18 ms (n=5) in the presence of 1 µM PKI 6–22
amide. The calculated increase of cAMP was 1.5±0.5 µM
and 1.4±0.04 µM in the presence of staurosporine or PKI
6–22 amide, respectively, revealing that PKA inhibitors
had no effect on the forskolin-induced increase of cAMP.
The only significant difference was seen in the delay
of maximal activation of endogenous ACs that increased
when PKA antagonists were applied. In the presence of
10 µM staurosporine the delay was 157±23 s (n=3) and
with 1 µM PKI 6–22 amide it was 176±25 s (n=5)
(Fig. 3B, C) as compared with 87±5 s during forskolin
application alone.
Co-expression of HvCNG channels with 
the m5-HT4(a)-receptor or the m5-HT1A-receptor
Co-expression of HvCNG channels together with recom-
binant m5-HT4(a)-receptors or m5-HT1A-receptors and
their Gs-proteins (αs-, β1-, γ2-subunits) or Gi-proteins(αi2-, β1-, γ2-subunits) affirmed that HvCNG channels
can also be used as endogenous sensors for the intracel-
lular cAMP changes that were induced by receptor acti-
vation. Expression of the m5-HT4(a)-receptor and the
m5-HT1A-receptor together with heteromeric Gs-protein
or Gi-protein was verified by Western blot analysis of the
infected Sf.9 cells using appropriate antibodies
(Fig. 4B).
In order to test whether serotonin (5-HT) is able to in-
duce endogenous currents, we did several controls:
1. We applied 5-HT to Sf.9 cells that were infected only
with m5-HT4(a)-receptors (n=5, not shown) and also
to Sf.9 cells co-expressing m5-HT4(a)-receptors to-
gether with the Gs-proteins (αs-, β1-, γ2-subunits)(n=4, Fig. 4A) both without the HvCNG channel.
2. We also tested cells that co-expressed HvCNG chan-
nels and m5-HT4(a)-receptors without the Gs-protein(n=4, Fig. 4A).
In none of the tests did we observe any significant
changes of currents during and after application of
100 µM 5-HT.
Responses to application of 5-HT were only seen in
10–15% of cells infected with viruses encoding for all
Fig. 4A, B Transfection with different baculoviruses encoding for
HvCNG channel, 5-HT4(a)-receptor and heterotrimeric G-protein
subunits αs, β1 and γ2. A Current–voltage (I–V) relationship show-
ing no difference between currents recorded before (❏) and after
() application of 100 µM 5-HT in cells that co-expressed the 5-
HT4(a)-receptor and the Gαs-, Gβ1- and Gγ2-subunits without the
HvCNG channel (n=4) or cells that co-express the HvCNG chan-
nel together with the 5-HT4(a)-receptor (❍/), but without G-pro-
tein subunits (n=4). B Sf.9 cells infected with recombinant baculo-
viruses encoding for HvCNG channel, 5-HT4(a)-receptor, Gαs-,
Gβ1- and Gγ2-subunits of heterotrimeric G-protein were harvested
48 h post-infection, washed with ice-cold PBS and resuspended in
Tris/EDTA buffer. Probes were boiled in non-reducing electropho-
resis sample buffer, separated on the 10% gel by the SDS-PAGE
and then subjected to Western blotting with antibody AS9459
raised against the C-terminus of the 5-HT4(a)-receptor, with anti-
bodies against the Gαs-subunit, with antibodies AS398 against β-
subunits (β1–β4) and AS292 against the γ-subunits (γ2+γ3). In all
cases polypeptide bands at the expected size were detected. The
fluorogram shown is one of two independent experiments
dose–response curve and may cause an overestimation of
cAMP.
The τa values of some co-infected cells indicated that
the intracellular cAMP level was elevated to 5 µM even
under control conditions. This may indicate that over-ex-
pressed receptors reveal a basal activity that affects en-
dogenous cAMP levels as described elsewhere [7]. On
average, however, cAMP levels of 1.9±1.02 µM
(τa=467±75; n=6) were not significantly different from
the basal cAMP levels of 1.5±0.3 µM (τa=571±33; n=49)
measured in Sf.9 cells that were only infected with the
HvCNG channel.
Sf.9 cells, which were transfected with m5-HT1A-re-
ceptor and Gi-protein (αi2-, β1-, γ2-subunits), revealed an
inhibitory response to 0.1 µM 5-HT (Fig. 5B). Applica-
tion of 0.1 µM 5-HT decreased the cAMP level to
0.4±0.06 µM. τa increased from 545±57 ms to
805±41 ms, which returned to 662±32 ms after wash-out
(n=3). The basal cAMP level was 1.5±0.3 µM
(437±36 ms). The delay to reach stable current kinetics
was 183±32 s.
The strong fluctuation of the τa values at the start of
5-HT application and during wash-out may reflect the
activity of intracellular factors modulating the HvCNG
channel activation kinetic, such as AC, PDE and protein
phosphorylation, that we did not control in these experi-
ments. However, especially for the estimation of cAMP
we are in the linear range of the dose–response curve and
have a highly sensitive tool for measuring even small
changes of cAMP.
Discussion
In the present study we determine quantitatively the in-
tracellular cAMP level and its change after pharmaco-
logical (forskolin, PKI, staurosporine) or molecular (m5-
HT4(a)-, m5-HT1A-receptor, Gs-, Gi-protein) manipula-
tions of intracellular signalling pathways. The recombi-
nant HvCNG channel from the antennae of the moth He-
liothis virecens was used as a sensor for intracellular
cAMP. Several other ingenious methods have been de-
veloped [1, 29, 34] for performing a comparable quanti-
fication of the intracellular level of cyclic nucleotides.
These methods are, however, very sophisticated and dif-
ficult to perform [29, 34]. They estimated that the cyto-
solic cyclic nucleotide concentration reaches maximally
at 5 µM. Here we present a technique to estimate cAMP
levels with HvCNG channels as biosensors, which have
several advantages.
Advantages of the HvCNG channel
The HvCNG channel is favoured by its dual dependence
on voltage and cAMP. CNG channels, which have been
used in other investigations to determine the cAMP level
[24, 29], monitor cAMP or cGMP levels as a function of
current amplitudes. The limitation of this technique is
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three components, e.g. HvCNG channels, m5-HT4(a)-re-
ceptors and Gs-proteins. These cells revealed maximal
activation of HvCNG-channel-mediated currents 70±4 s
(n=6) after exposure to 5-HT. τa decreased from
769±66 ms to 310±38 ms (4.6±1.45 µM cAMP) in re-
sponse to 0.1 µM 5-HT, while τa increased again to
701±123 ms after wash-out (Fig. 5A). Repetitive appli-
cations of 5-HT induced a decline of responses
(Fig. 5A). A tenfold elevation of the 5-HT concentration
(1 µM) was not as effective at decreasing τa as compared
with the first application of 0.1 M 5-HT. The decrease of
the second response is clearly to be seen in the estima-
tion of cAMP according to the dose–response curve in
Fig. 1C. However, one has to be aware that the calculat-
ed cAMP levels during the first application correspond
to τa values that are in the saturating range of the
Fig. 5A, B Co-expression of recombinant m5-HT-receptors, G-
protein subunits and the HvCNG channel in Sf.9 cells. A Stimula-
tion by 0.1 µM 5-HT induced a pronounced decrease of τa of the
evoked currents in Sf.9 cells expressing the m5-HT4a-receptor, the
G-protein-subunits αs, β1, γ2 and the HvCNG channel. The time
course shows a steep decrease of τa from 769±66 ms to
309±38 ms (n=6). The time to reach maximal activation was
70±4 s (n=6) for applications of 0.1 µM 5-HT. Repetitive stimula-
tion of the m5-HT4a-receptor revealed a strong reduction of the re-
sponse to the second 5-HT application even at higher 5-HT con-
centrations. B Stimulation by 0.1 µM 5-HT induced an increase of
τa in Sf.9 cells that had expressed the m5-HT1A-receptor, the G-
protein-subunits αi2, β1, γ2 and the HvCNG channel. The time
course shows a slow increase of τa from 545±57 ms to 805±41 ms(n=3). The time to reach maximal activation was 183±32 s (n=6)
for applications of 0.1 µM 5-HT
that the current amplitude depends on the expression lev-
el of the channel. Therefore, the use of CNG channels
demands a difficult calibration of the level of CNG chan-
nel expression within each cell. The method described
here is independent of the expression level because the
measurements rely on the cAMP-induced kinetic shift in
current activation as a direct parameter of the cAMP lev-
el. This allowed us to measure intracellular cAMP levels
by the cAMP-dependent changes of the activation time
constants independently from the expression level of
HvCNG channels. Another advantage of the method is
that the parameter is resistant to any wash-out effects
during the period of whole-cell recordings. Electrodes
containing defined concentrations of cAMP allowed ac-
curate calibration. The parameter is also highly sensitive
over a broad concentration range of 0.1–5 µM cAMP,
which enables us to measure even small changes of the
cAMP concentration.
Involvement of protein kinases in channel activation
To investigate whether cAMP acts directly on the
HvCNG channel as reported for another HCN channel
[8], we used staurosporine (10 µM) and PKI 6–22 amide
(1 µM) to block any possible contributions of protein
kinases, especially PKC and PKA. There was no effect
on the forskolin-induced change of intracellular cAMP,
but there was a significant increase in the rise time to
reach maximal levels. This prolongation of the activation
time was similar for the two antagonists and therefore
may indicate the involvement of PKA in the process of
HvCNG channel activation. Sequence analysis of the
HvCNG channel has indeed demonstrated that there are
ten putative phosphorylation sites for PKC and two
phosphorylation sites for a tyrosine kinase [14]. HCN
channels can be influenced by phosphorylation [6, 25,
30], which may play a role in the activation of the
HvCNG channel. However, our investigations do support
an action of PKA on the channel protein.
Forskolin-induced changes of the cAMP concentration
indicate the existence of functional microdomains
As shown recently in C6–2B glioma cells and in HEK-
293 cells, activation of ACs primarily induces a build-up
of cAMP levels that are spatially restricted to microdo-
mains, which is followed by a much slower increase of
cAMP in the cytosol [24]. In their investigation Rich et
al. [24] postulated a co-localization of olfactory CNG
channels and ACs.
The Sf.9 cells have fairly weak endogenous currents
[31] that may interfere with the expressed HvCNG chan-
nel (Fig. 4A). However, Sf.9-cells have the capacity to
effectively produce measurable cAMP changes, as dem-
onstrated by the forskolin-induced activation of ACs
(Fig. 3). However, forskolin (50 µM) could not potenti-
ate HvCNG channels as effectively as saturating concen-
trations (100 µM) of cAMP applied via the pipette solu-
tion. This became evident in the forskolin-induced
(50 µM) shift of V1/2 by +12.9 mV, which was much less
than the +28.5-mV shift of V1/2 obtained by perfusion of
cAMP via the patch pipette. This indicates a restricted
ability of the membrane-delimited ACs to elevate local
cAMP levels and/or good efficiency of the endogenous
PDEs. Inhibition of PDE activity by application of the
unspecific antagonist IBMX did not influence the basal
cAMP level or may not affect the endogenous PDEs (da-
ta not shown). However, endogenous PDEs are not effec-
tive below 0.9 µM intracellular cAMP, as indicated by
the basal cAMP level measured in the presence of the
AC antagonist MDL 12330A.
Krieger et al. [14] reported a Hill factor of 1 based on
measurements of the HvCNG channel's responses in in-
side-out patches that were exposed to different cAMP
concentrations. Such inside-out patches are not compara-
ble with a whole-cell configuration. Thus, the Hill factor
of 1.5, as revealed in our experiments, indicates that
PDE activity is high (above 1 µM cAMP) and probably
not present in inside-out patches.
The forskolin-induced effects on the current kinetics
as observed under whole-cell conditions supports the re-
sults described elsewhere [24], namely that cAMP in-
creases in microdomains with restricted diffusion into
the cytosol. The lack of wash-out seen in the present ex-
periments is also consistent with this view.
Receptor-induced changes of cAMP
There is no indication that endogenous ion channels con-
tribute to the 5-HT-induced response of the co-expressed
HvCNG channels (Fig. 4A). The observed changes of τa
are only related to the expressed 5-HT receptors and G-
protein subunits.
The time course of the 5-HT-induced cAMP increase
is not significantly different from that of the cAMP
changes induced by forskolin. This encourages us to ar-
gue that heterologously expressed components are aggre-
gated in subcellular compartments; otherwise, one would
expect longer time courses of changes in the current ki-
netics during 5-HT application because of longer diffu-
sion distances.
Repetitive applications of 5-HT showed that the het-
erologously expressed 5-HT4(a)-receptor desensitized af-
ter the first 5-HT application.
Another feature of the m5-HT4(a)-receptor and dif-
ferent splice variants of the m5-HT4-receptor is their
high basal activity [7]. Following the hypothesis that
the cAMP concentration in a subcellular domain around
the AC is high and diffusion of cAMP out of this do-
main is impeded, we determined the basal activity in
whole-cell recordings performed shortly after break-
through of the membrane. In some cells we observed a
higher basal activity that was not washed out even after
a longer diffusion time, but the mean value was not sig-
nificantly different from the basal activity measured in
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Sf.9-cells, which were infected by the HvCNG channel
alone.
To demonstrate that the Sf.9 expression system is val-
id for measuring an increase and a decrease of cAMP,
we expressed the recombinant m5-HT1A-receptor togeth-
er with Gi-protein (αi2-, β1-, γ2-subunits). We observed a
reversible increase of τa and therefore a decrease of
cAMP in response to 0.1 µM 5-HT (Fig. 5). We assume
that the slow time course of the cAMP decline indicates
a slow rate of cAMP degradation or diffusion. As sug-
gested by the Hill factor, there is efficient PDE-regulated
degradation of higher cAMP levels that determines the
decline of cAMP levels after the AC activity is de-
creased by the αi-subunit. Several processes might inter-
act to bring about the long degradation time of cAMP af-
ter m5-HT1A-receptor stimulation. Firstly, PDE may not
be efficient enough to change the cAMP concentration in
a shorter time in this concentration range, as indicated by
the basal cAMP level measured after prolonged blockade
of endogenous ACs by MDL 12330A. Secondly, there is
indication of a diffusional process out of the microdo-
main, with impeded diffusion into the cytosol [24].
We measured membrane-delimited cAMP levels at
the effectors that are regulated by cAMP. This should be
used as a tool for obtaining valuable information about
the molecular machinery of intracellular signalling with-
in the microenvironment of cAMP target structures.
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